{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:58Z","timestamp":1792788358462,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Provincial Commission of Health Science Project","award":["20PJ059"],"award-info":[{"award-number":["20PJ059"]}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital,Sichuan University","award":["ZYJC21049"],"award-info":[{"award-number":["ZYJC21049"]}],"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence\u2013Clinical Research Incubation Project, West China Hospital, Sichuan University","award":["20HXFH021"],"award-info":[{"award-number":["20HXFH021"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81900516"],"award-info":[{"award-number":["No.81900516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82002578"],"award-info":[{"award-number":["No.82002578"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20188-0","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:48:50Z","timestamp":1784216930000},"page":"8807-8815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Evaluation of Survival, Surgical Conversion, and Toxicity for Induction Therapy in Initially Unresectable Colorectal Liver Metastases: An Individual Patient Data Network Meta-analysis"],"prefix":"10.1245","volume":"33","author":[{"given":"Guilin","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"19","key":"20188_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/jnci\/djh275","volume":"96","author":"JB Connell","year":"2004","unstructured":"Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420\u20135. https:\/\/doi.org\/10.1093\/jnci\/djh275.","journal-title":"J Natl Cancer Inst."},{"issue":"7","key":"20188_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/s1470-2045(23)00219-x","volume":"24","author":"MJG Bond","year":"2023","unstructured":"Bond MJG, Bolhuis K, Loosveld OJL, et al. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group. Lancet Oncol. 2023;24(7):757\u201371. https:\/\/doi.org\/10.1016\/s1470-2045(23)00219-x.","journal-title":"Lancet Oncol."},{"issue":"3","key":"20188_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309\u201321. https:\/\/doi.org\/10.1097\/00000658-199909000-00004.","journal-title":"Ann Surg."},{"issue":"7","key":"20188_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","volume":"77","author":"B Nordlinger","year":"1996","unstructured":"Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Association Fran\u00e7aise de Chirurgie. Cancer. 1996;77(7):1254\u201362.","journal-title":"Cancer."},{"issue":"4","key":"20188_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644\u201358. https:\/\/doi.org\/10.1097\/01.sla.0000141198.92114.f6.","journal-title":"Ann Surg."},{"issue":"3","key":"20188_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/jco.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris VK, Kennedy EB, Baxter NN, et al. Treatment of metastatic colorectal cancer: ASCO guideline. J Clin Oncol. 2023;41(3):678\u2013700. https:\/\/doi.org\/10.1200\/jco.22.01690.","journal-title":"J Clin Oncol."},{"issue":"14","key":"20188_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","volume":"360","author":"E Van Cutsem","year":"2009","unstructured":"Van Cutsem E, K\u00f6hne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408\u201317. https:\/\/doi.org\/10.1056\/NEJMoa0805019.","journal-title":"N Engl J Med."},{"issue":"3","key":"20188_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41416-019-0518-2","volume":"121","author":"E Oki","year":"2019","unstructured":"Oki E, Emi Y, Yamanaka T, et al. Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). Br J Cancer. 2019;121(3):222\u20139. https:\/\/doi.org\/10.1038\/s41416-019-0518-2.","journal-title":"Br J Cancer."},{"issue":"1","key":"20188_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143. https:\/\/doi.org\/10.1186\/s12943-021-01441-4.","journal-title":"Mol Cancer."},{"key":"20188_CR10","doi-asserted-by":"publisher","first-page":"e086026","DOI":"10.1136\/bmj-2025-086026","volume":"391","author":"BD Qin","year":"2025","unstructured":"Qin BD, Jiao XD, Wang Z, et al. Targeted therapy in advanced BRAF-mutated colorectal cancer: systematic review and network meta-analysis. Bmj. 2025;391:e086026. https:\/\/doi.org\/10.1136\/bmj-2025-086026.","journal-title":"Bmj."},{"key":"20188_CR11","doi-asserted-by":"publisher","first-page":"1439624","DOI":"10.3389\/fimmu.2024.1439624","volume":"15","author":"K Chen","year":"2024","unstructured":"Chen K, Chen W, Yue R, et al. Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials. Front Immunol. 2024;15:1439624. https:\/\/doi.org\/10.3389\/fimmu.2024.1439624.","journal-title":"Front Immunol."},{"issue":"2","key":"20188_CR12","doi-asserted-by":"publisher","first-page":"znae021","DOI":"10.1093\/bjs\/znae021","volume":"111","author":"D Aliseda","year":"2024","unstructured":"Aliseda D, Arredondo J, S\u00e1nchez-Justicia C, et al. Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis. Br J Surg. 2024;111(2):znae021. https:\/\/doi.org\/10.1093\/bjs\/znae021.","journal-title":"Br J Surg."},{"key":"20188_CR13","doi-asserted-by":"publisher","first-page":"1374136","DOI":"10.3389\/fphar.2024.1374136","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Shao T, Zhao M, Xue Y, Zheng X. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases. Front Pharmacol. 2024;15:1374136. https:\/\/doi.org\/10.3389\/fphar.2024.1374136.","journal-title":"Front Pharmacol."},{"issue":"1","key":"20188_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0272989x221126678","volume":"43","author":"I Bellos","year":"2023","unstructured":"Bellos I. Multicriteria decision-making methods for optimal treatment selection in network meta-analysis. Med Decis Making. 2023;43(1):78\u201390. https:\/\/doi.org\/10.1177\/0272989x221126678.","journal-title":"Med Decis Making."},{"issue":"16","key":"20188_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657\u201365. https:\/\/doi.org\/10.1001\/jama.2015.3656.","journal-title":"JAMA."},{"issue":"9","key":"20188_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41416-021-01644-y","volume":"126","author":"M Ychou","year":"2022","unstructured":"Ychou M, Rivoire M, Thezenas S, et al. Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial. Br J Cancer. 2022;126(9):1264\u201370. https:\/\/doi.org\/10.1038\/s41416-021-01644-y.","journal-title":"Br J Cancer."},{"issue":"1","key":"20188_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","volume":"21","author":"N Liu","year":"2021","unstructured":"Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21(1):111. https:\/\/doi.org\/10.1186\/s12874-021-01308-8.","journal-title":"BMC Med Res Methodol."},{"issue":"5","key":"20188_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/sim.7141","volume":"36","author":"DL Burke","year":"2017","unstructured":"Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med. 2017;36(5):855\u201375. https:\/\/doi.org\/10.1002\/sim.7141.","journal-title":"Stat Med."},{"issue":"10","key":"20188_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046042","volume":"7","author":"GB Stewart","year":"2012","unstructured":"Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA. Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One. 2012;7(10):e46042. https:\/\/doi.org\/10.1371\/journal.pone.0046042.","journal-title":"PLoS One."},{"issue":"13","key":"20188_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1001\/jama.2023.17465","volume":"330","author":"M S\u00e1nchez-de-la-Torre","year":"2023","unstructured":"S\u00e1nchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, et al. Adherence to CPAP treatment and the risk of recurrent cardiovascular events: a meta-analysis. JAMA. 2023;330(13):1255\u201365. https:\/\/doi.org\/10.1001\/jama.2023.17465.","journal-title":"JAMA."},{"issue":"4","key":"20188_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamapsychiatry.2020.4364","volume":"78","author":"E Karyotaki","year":"2021","unstructured":"Karyotaki E, Efthimiou O, Miguel C, et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry. 2021;78(4):361\u201371. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.4364.","journal-title":"JAMA Psychiatry."},{"issue":"8","key":"20188_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamapediatrics.2024.1848","volume":"178","author":"JX Sotiropoulos","year":"2024","unstructured":"Sotiropoulos JX, Oei JL, Schm\u00f6lzer GM, et al. Initial oxygen concentration for the resuscitation of infants born at less than 32 weeks\u2019 gestation: a systematic review and individual participant data network meta-analysis. JAMA Pediatr. 2024;178(8):774\u201383. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.1848.","journal-title":"JAMA Pediatr."},{"issue":"3","key":"20188_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/rssa.12579","volume":"183","author":"DM Phillippo","year":"2020","unstructured":"Phillippo DM, Dias S, Ades AE, et al. Multilevel network meta-regression for population-adjusted treatment comparisons. J R Stat Soc Ser A Stat Soc. 2020;183(3):1189\u2013210. https:\/\/doi.org\/10.1111\/rssa.12579.","journal-title":"J R Stat Soc Ser A Stat Soc."},{"issue":"27","key":"20188_CR24","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1200\/jco.20.00174","volume":"38","author":"W Tang","year":"2020","unstructured":"Tang W, Ren L, Liu T, et al. Bevacizumab plus mFOLFOX6 versus mFOLFOX6 alone as first-line treatment for RAS mutant unresectable colorectal liver-limited metastases: the BECOME randomized controlled trial. J Clin Oncol. 2020;38(27):3175\u201384. https:\/\/doi.org\/10.1200\/jco.20.00174.","journal-title":"J Clin Oncol."},{"issue":"5","key":"20188_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004389","volume":"21","author":"DS Wang","year":"2024","unstructured":"Wang DS, Ren C, Li SS, et al. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS\/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): a randomized controlled trial. PLoS Med. 2024;21(5):e1004389. https:\/\/doi.org\/10.1371\/journal.pmed.1004389.","journal-title":"PLoS Med."},{"issue":"1","key":"20188_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/s1470-2045(09)70330-4","volume":"11","author":"G Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11(1):38\u201347. https:\/\/doi.org\/10.1016\/s1470-2045(09)70330-4.","journal-title":"Lancet Oncol."},{"issue":"4","key":"20188_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/annonc\/mdu580","volume":"26","author":"T Gruenberger","year":"2015","unstructured":"Gruenberger T, Bridgewater J, Chau I, et al. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26(4):702\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdu580.","journal-title":"Ann Oncol."},{"issue":"16","key":"20188_CR28","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1200\/jco.2012.44.8308","volume":"31","author":"LC Ye","year":"2013","unstructured":"Ye LC, Liu TS, Ren L, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol. 2013;31(16):1931\u20138. https:\/\/doi.org\/10.1200\/jco.2012.44.8308.","journal-title":"J Clin Oncol."},{"issue":"1","key":"20188_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jamaoncol.2024.5174","volume":"11","author":"MJG Bond","year":"2025","unstructured":"Bond MJG, Bolhuis K, Loosveld OJL, et al. First-line systemic treatment for initially unresectable colorectal liver metastases: post hoc analysis of the CAIRO5 randomized clinical trial. JAMA Oncol. 2025;11(1):36\u201345. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5174.","journal-title":"JAMA Oncol."},{"key":"20188_CR30","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.01225","author":"C Cremolini","year":"2020","unstructured":"Cremolini C, Antoniotti C, Stein A, et al. Individual patient data meta-analysis of FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer. J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/jco.20.01225.","journal-title":"J Clin Oncol."},{"issue":"4","key":"20188_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s1470-2045(19)30862-9","volume":"21","author":"C Cremolini","year":"2020","unstructured":"Cremolini C, Antoniotti C, Rossini D, et al. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol. 2020;21(4):497\u2013507. https:\/\/doi.org\/10.1016\/s1470-2045(19)30862-9.","journal-title":"Lancet Oncol."},{"issue":"10","key":"20188_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/cac2.70047","volume":"45","author":"Y Zhan","year":"2025","unstructured":"Zhan Y, Xu J, Zhang Z, et al. Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis. Cancer Commun (Lond). 2025;45(10):1203\u201328. https:\/\/doi.org\/10.1002\/cac2.70047.","journal-title":"Cancer Commun (Lond)."},{"issue":"1","key":"20188_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-024-01643-5","volume":"17","author":"H Fang","year":"2024","unstructured":"Fang H, Dai W, Gu R, et al. myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment. J Hematol Oncol. 2024;17(1):126. https:\/\/doi.org\/10.1186\/s13045-024-01643-5.","journal-title":"J Hematol Oncol."},{"issue":"20","key":"20188_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413095","volume":"12","author":"J Cai","year":"2025","unstructured":"Cai J, Zhang P, Cai Y, et al. Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma. Adv Sci (Weinh). 2025;12(20):e2413095. https:\/\/doi.org\/10.1002\/advs.202413095.","journal-title":"Adv Sci (Weinh)."},{"key":"20188_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104946","volume":"216","author":"A Zhang","year":"2025","unstructured":"Zhang A, Zhang Y, Xu J, Zhu R, Liang T, Guo L. Molecular landscape of colorectal cancer liver metastasis: tumor microenvironment heterogeneity and driver inference. Crit Rev Oncol Hematol. 2025;216:104946. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104946.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"20188_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaoncol.2024.5073","volume":"11","author":"J Franko","year":"2025","unstructured":"Franko J, Le VH. FOLFOX\/FOLFIRI-bevacizumab for unresectable colorectal liver metastases. JAMA Oncol. 2025;11(1):13\u20135. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5073.","journal-title":"JAMA Oncol."},{"issue":"7","key":"20188_CR37","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1245\/s10434-024-15187-y","volume":"31","author":"K Sugumar","year":"2024","unstructured":"Sugumar K, Stitzel H, Wu V, et al. Outcomes of hepatic artery-based therapies and systemic multiagent chemotherapy in unresectable colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2024;31(7):4413\u201326. https:\/\/doi.org\/10.1245\/s10434-024-15187-y.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20188-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:19Z","timestamp":1789667599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20188"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20188-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}